Outcomes-Based Agreements Give New Insight for Treatment of Diabetes and Cardiovascular Disease

This AJMC^® Profiles in Care provides an in-depth look into the results of the innovative outcomes-based agreement between Boehringer Ingelheim and Highmark Inc that focused on total cost of care for patients with type 2 diabetes and cardiovascular disease. An overview of the results, as well as valuable insights from experts from Boehringer Ingelheim and Highmark, are included.

Download PDF: Outcomes-Based Agreements Give New Insight for Treatment of Diabetes and Cardiovascular Disease